Report
Nitin Aggarwal

MOSL: ICICI BANK (Buy)-Board appoints new MD & CEO

ICICI BANK: Board appoints new MD & CEO; Clarity on top management to support re-rating

(ICICIBC IN, Mkt Cap USD27.6b, CMP INR316, TP INR380, 20% Upside, Buy)

 

  • ICICI Bank’s (ICICIBC) board has accepted the request of Ms Chanda Kochhar for early retirement with immediate effect.
  • The board appointed Mr Sandeep Bakhshi as MD & CEO for a period of five years until 3rd October 2023, subject to regulatory and other approvals.
  • Ms Kochhar will also relinquish office from the board of the bank's subsidiaries.

 We believe that ICICIBC’s board decision to accept Ms Kochhar’s request for early retirement removes a major overhang on the stock and will likely help improve market perception of transparency and governance at ICICIBC. While Mr Bakhshi presented last quarterly results at ICICIBC, the upcoming results announcement now becomes much more important as it will provide much-needed clarity on the bank’s performance and the revised business strategy under the new leadership. We expect the bank to deliver 1.1% RoA/11% RoE by FY20, which should expand further thereafter. We reiterate our Buy rating on ICICIBC – one of our top picks in the banking sector – with an SOTP-based TP of INR380 (1.8x Mar’20E ABV).

A major overhang cleared – ICICIBC gets new MD & CEO: The appointment of Mr Bakhshi as MD & CEO has cleared the uncertainty around top management at ICICIBC. We believe that the development has raised hopes of a quicker turnaround in the bank’s earnings/business performance. Mr Bakhshi has been associated with ICICI Group for 32 years and also served as CEO at two well-performing subsidiaries – ICICI Prudential Life and ICICI Lombard – early in his career. We believe that Mr Bakhshi taking over the reins at a time when the corporate NPL cycle is in its last leg will enable ICICIBC to strategize well on its journey and alongside generate significant returns for its stakeholders. Under the leadership of Ms Kochhar, ICICIBC had shared its strategy to achieve 15% consolidated RoE by Jun-20 and a net NPL ratio of <1.5% by Mar-20.

Underlying
ICICI Bank Limited

ICICI Bank Limited is a banking company. The Bank is engaged in providing a range of banking and financial services, including commercial banking, retail banking, project and corporate finance, working capital finance, insurance, venture capital and private equity, investment banking, broking and treasury products and services. The Bank's business segments are Retail banking, Wholesale banking, Treasury, Other banking, Life insurance, General insurance and Others. It has a network of approximately 18,210 branches and automated teller machines (ATMs). The Bank has approximately 110 Touch Banking branches across over 30 cities. Its international banking is focused on providing solutions for the international banking requirements of its Indian corporate clients and leveraging economic corridors between India and the rest of the world. The Bank caters to the financial needs of women entrepreneurs through its Self-Help Group (SHG) program as a part of its microfinance initiatives.

Provider
Motilal Oswal
Motilal Oswal

​Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance. 

Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.

Analysts
Nitin Aggarwal

Other Reports on these Companies
Other Reports from Motilal Oswal

ResearchPool Subscriptions

Get the most out of your insights

Get in touch